REMED BrainStim
Latest round
- Seed
Last raised
- May 2023
Total raised
- $2.6M
Investors
- 2
About REMED BrainStim
Founded in 2020 and based in Gyeonggi-do, South Korea, REMED BrainStim operates as a neurological health company that offers transcranial magnetic stimulation devices. The company specializes in transcranial magnetic stimulation (TMS), a noninvasive treatment that involves using a magnetic coil to modify the natural electrical activity of the patient's brain. The company offers a variety of products, such as Mensa: Mon is a learning aid device that uses electromagnetic stimulation to help users improve their concentration and memory; emQure activates the frontal and temporal lobes associated with memory formation to improve language memory and cognitive function; emFree is a miniaturized version of TMS for depression treatment that has the most clinical data among various TMS treatments; and hair breath is a product that overcomes the limitations of existing laser treatments. NextQure also provides a network platform for managing patients' continuous therapy. The organization intends to utilize the funds from May 2023 to promote household acceptance of its transcranial magnetic stimulation devices as well as to create new products for the treatment of intractable diseases, emotional therapy, addiction treatment, and sleep therapy.
Who invested in REMED BrainStim
2 investors across 1 round
See all investors in REMED BrainStim
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 26, 2023
Amount
$2.6M
Investors
Questions about REMED BrainStim
Who invested in REMED BrainStim?
REMED BrainStim has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has REMED BrainStim raised?
REMED BrainStim has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did REMED BrainStim last raise money?
REMED BrainStim's most recent round on record is a Seed, in May 2023.
What does REMED BrainStim do?
Founded in 2020 and based in Gyeonggi-do, South Korea, REMED BrainStim operates as a neurological health company that offers transcranial magnetic stimulation devices.
Where is REMED BrainStim headquartered?
REMED BrainStim is headquartered in Seongnam-si, South Korea.
Which VCs invest in companies like REMED BrainStim?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at REMED BrainStim's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like REMED BrainStim? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.